Trial Profile
Compassionate Use of Erwinase [asparaginase] For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2017
Price :
$35
*
At a glance
- Drugs Crisantaspase (Primary)
- Indications Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms ERWASE
- 04 Jan 2012 Actual patient number (87) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Actual end date (1 Dec 2011 ) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.